Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol-HFA versus Foradil Aerolizer in children with persistent asthma
2004-000755-41Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of formoterol in persistent asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Predose morning peak expiratory flow. Started Aug 2004; status: completed.
02
Drugs
formoterol
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2004-000755-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000755-41.